Concepedia

Author

H.U. Bryant

Eli Lilly (United States)

Also Known As

H BRYANT, H Bryant, H U Bryant, H. Bryant, H. U. BRYANT, H. U. Bryant, H.U Bryant, H.U. Bryant, Hugh Bryant

50

Publications

1.6K

Citations

21

H-Index

57

Concepts

All Affiliations

Eli Lilly (United States)Colorado State UniversityWalter Reed Army Institute of ResearchWestern UniversityMayo Clinic
HB

About

H.U. Bryant is an author at Eli Lilly (United States) specializing in medicine, endocrinology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

14

809

2

Health Sciences

6

6

341

3

Public Health

3

3

103

4

Education

2

2

45

5

Cell Biology

2

2

181

H.U. Bryant

×

25

Publications

1.3K

Citations

19

H-Index

YearCitations

Raloxifene preserves bone strength and bone mass in ovariectomized rats.

Charles H. Turner, Masahiko Sato, H.U. Bryant

Endocrinology

1994

164

Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.

Na Yang, H.U. Bryant, Sushant Hardikar,

Endocrinology

1996

139

Morphine pellet-induced immunomodulation in mice: temporal relationships.

H.U. Bryant, Edward W. Bernton, John W. Holaday

Journal of Pharmacology and Experimental Therapeutics

1988

127

Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.

Masahiko Sato, J Kim, Lorri L. Short,

Journal of Pharmacology and Experimental Therapeutics

1995

119

Role of Adrenal Cortical Activation in the Immunosuppressive Effects of Chronic Morphine Treatment*

H.U. Bryant, Edward W. Bernton, Julie Kenner,

Endocrinology

1991

112

Suppressive effects of morphine pellet implants on in vivo parameters of immune function.

H.U. Bryant, Roger E. Roudebush

Journal of Pharmacology and Experimental Therapeutics

1990

102

Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor

Robin Fuchs‐Young, A. L. GLASEBROOK, Lorri L. Short,

Annals of the New York Academy of Sciences

1995

87

Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.

Glenda L. Evans, H.U. Bryant, David E. Magee,

Endocrinology

1996

74

Dose-response effects of estradiol implants on bone mineral density in ovariectomized ewes

A. Simon Turner, Craig Mallinckrodt, Mark Alvis,

Bone

1995

44

Differential Effects of Estrogen and Raloxifene on Messenger RNA and Matrix Metalloproteinase 2 Activity in the Rat Uterus

Leah M. Helvering, Mary D. Adrian, Andrew G. Geiser,

Biology of Reproduction

2004

42

Page 1